Locations:
Search
Cleveland Clinic inventors have pioneered AI-driven software that analyzes retinal imaging data with unprecedented precision. Led by Justis P. Ehlers, MD, and Sunil Srivastava, MD, this technology extracts critical information from optical coherence tomography scans to enhance disease detection, predict treatment outcomes, and establish new endpoints for clinical trials in ophthalmology.
Cleveland Clinic's Innovation Fellows program has sparked the development of PowerCut, a tool modernizing spinal rod manipulation techniques unchanged for decades. Advanced through the collaborative work of Kyle O'Laughlin, MS, Lead Research Technologist, Biomedical Engineering, Cleveland Clinic, this device aims to transform scoliosis surgeries by replacing manual bending methods with a smaller, more efficient alternative that streamlines procedures and expands capabilities across surgical teams.
Cleveland Clinic Innovations is proud to highlight the creativity and problem-solving spirit of our nurses through the Nurse Inventor Spotlight series. This series highlights nurses’ innovation journeys, inspirations, how nurses and teams identify unmet needs, and the impact of unmet needs and innovations on patients and caregivers.
by Saqib Sachani, PhD, MBA, Director, Innovations Business Development and Licensing
As healthcare marches into 2025, the industry stands on the brink of pivotal changes. Venture funding for digital health is regaining momentum, particularly for solutions that modernize infrastructure, enhance care delivery, and empower patients. Todd Schwarzinger, MBA, Partner, Cleveland Clinic Innovations Ventures, shares insights on how new partnerships and technologies are reshaping the future of care.
At the forefront of biological therapeutics development, Feng Lin, PhD, of Cleveland Clinic is revolutionizing the field through groundbreaking research in antibody development and strategic industry partnerships. His work spans from innovative cancer treatments to complement-mediated disease therapies, marking a new era in biological therapeutic solutions.
By Mohamed Ramadan, PhD, MBA, General Manager, Cleveland Clinic Innovations Development
Cleveland Clinic developed Autism Eyes, an eye-tracking technology that detects autism markers by analyzing how children view images. Acquired in early 2024, this technology aims to reduce the typical one-to-three-year delay between noticing symptoms and receiving a formal autism diagnosis.
